An interleukin-17–mediated paracrine network promotes tumor resistance to anti-angiogenic therapy

Alicia S. Chung, Xiumin Wu(Genentech), Guanglei Zhuang(Genentech), Hai Ngu, Ian Kasman(University of California, San Diego), Jianhua Zhang(Cellular Biomedicine Group (United States)), Jean-Michel Vernes(Genentech), Zhaoshi Jiang, Y. Gloria Meng(Genentech), Franklin Peale, Wenjun Ouyang(Genentech), Napoleone Ferrara(University of California, San Diego)

Nature Medicine

August 4, 2013

10.1038/nm.3291

Cited by 444

Abstract

Related Papers

Myeloid-derived suppressor cells as regulators of the immune system

Dmitry I. Gabrilovich, Srinivas Nagaraj|Nature reviews. Immunology|2009|6.6k

The immune contexture in human tumours: impact on clinical outcome

Wolf H. Fridman, Franck Pagès, Catherine Sautès‐Fridman et al.|Nature reviews. Cancer|2012|4.9k

IL-17 and Th17 Cells

Thomas Korn, Estelle Bettelli, Mohamed Oukka et al.|Annual Review of Immunology|2009|4.8k

Coordinated regulation of myeloid cells by tumours

Dmitry I. Gabrilovich, Suzanne Ostrand‐Rosenberg, Vincenzo Bronte|Nature reviews. Immunology|2012|3.5k

Modes of resistance to anti-angiogenic therapy

Gabriele Bergers, Douglas Hanahan|Nature reviews. Cancer|2008|2.9k